[Adrenergic activation in heart failure: blockade or rebalance?]

G Ital Cardiol (Rome). 2010 Mar;11(3):229-32.
[Article in Italian]
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Clinical Trials as Topic
  • Heart Failure / drug therapy
  • Heart Failure / mortality
  • Heart Failure / physiopathology*
  • Heart Rate
  • Homeostasis
  • Humans
  • Myocardial Contraction
  • Nerve Growth Factor / physiology
  • Nerve Growth Factor / therapeutic use
  • Norepinephrine / blood
  • Receptors, Adrenergic, beta
  • Sympathetic Nervous System / physiology*
  • Time Factors
  • Up-Regulation
  • Ventricular Dysfunction / physiopathology
  • Ventricular Remodeling / physiology

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Receptors, Adrenergic, beta
  • Nerve Growth Factor
  • Norepinephrine